在一般实践中提高家族性高胆固醇血症的检测:在社区中支持遗传级联测试的模型
Jing Pang1, Wendy Barnett2, Jane Purdie2
1Medical School, University of Western Australia, Western Australia, Perth, Australia.
European journal of human genetics : EJHG
|November 18, 2025
概括
在一级亲属 (FDR) 中进行家族性高胆固醇血症 (FH) 的遗传检测是通过共享护理模式有效的. 这种方法成功地识别了FH,并改善了被诊断的亲属的LDL胆固醇水平.
科学领域:
- 心血管遗传学 心血管遗传学
- 公共卫生 公共卫生
- 主要护理医学 医疗保健
背景情况:
- 家族性高胆固醇血症 (FH) 是一种普遍的遗传性疾病,导致早发性冠状动脉疾病,在全球范围内经常被低诊断.
- 通过基因检测进行准确的诊断对于通过级联检测识别受影响的一级亲属至关重要.
- 一般医生对FH遗传检测的经验有限,需要新的护理模式.
研究的目的:
- 开发和评估一个三级-初级共享护理模型,用于在指数病例的FDR中识别遗传FH.
- 在这个模型中评估遗传级联测试的可行性,吸收和临床结果.
主要方法:
- 实施了共享护理模式,涉及全科医生 (GPs),由基因FH识别的第三级中心支持.
- 为90个FH指数病例中的153名FDR提供了基因测试,收集了吸收,产量和临床结果的数据.
- 在有或没有致病变体的亲属之间比较了LDL胆固醇水平,并评估了治疗结果.
主要成果:
- 在符合条件的FDR中,基因测试的普及率为95%,病原体变异的收益率为50%.
- 与没有病原变异的亲属相比,患有病原变异的亲属的LDL胆固醇水平显著更高 (5.9 ± 1.8 mmol/L) (2.7 ± 0.9 mmol/L).
- 在31名亲属开始治疗后,LDL胆固醇降低了46%,其中45%实现了指导目标.
结论:
- 一个三级和初级的共享护理模式促进了在FDR中有效的基因级联检测FH.
- 该模型证明了可行性和积极的临床结果,支持在社区环境中检测FH.
- 这些发现支持开发用于FH管理的集中,持续的护理模型.
更多相关视频
相关概念视频
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
424
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
424
Atherosclerosis III: Management
290
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
290
Genome-wide Association Studies-GWAS
15.2K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
15.2K


